Jaguar Animal Health to merge with Napo Pharmaceuticals

Merger will provide revenue stream to Jaguar from FDA-approved anti-diarrheal that offers novel mechanism of action.

Jaguar Animal Health Inc., an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals and high-value horses, announced Feb. 9 that it has entered into a binding agreement of terms to merge with Napo Pharmaceuticals Inc.

The transaction was approved by the unanimous vote of independent and disinterested members of each of Jaguar’s and Napo’s boards of directors. Napo will operate as

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.


Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)


Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit Feedstuffs.com and click on Subscribe at the top of the page for more information.


SUBSCRIBE NOW https://circulation.feedstuffs.com/Publications.aspx


TO RENEW YOUR SUBSCRIPTION https://circulation.feedstuffs.com/SubscriptionOffers.aspx


Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish